Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

S&P Biotech SPDR (NY: XBI )

79.32 -1.20 (-1.49%)
Official Closing Price Updated: 8:00 PM EST, Dec 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,324,834
Open 80.21
Bid (Size) 79.33 (6)
Ask (Size) 79.48 (1)
Prev. Close 80.52
Today's Range 79.22 - 81.13
52wk Range 63.80 - 92.60
Shares Outstanding 807,500
Dividend Yield 0.00%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Are These Biotechs Ready To Launch?
Biotech stocks are still in the process of repairing the damage from recent months — and recent years. Indeed, as of a month ago, the SPDR Biotech Fund had been dead money for an unbelievable eight and... 
Via Talk Markets
Can Small Cap Biotech Stocks Continue To Run? Let’s Take A Look
Over the past 4 weeks, we have seen a nice run in small-cap, speculative biotech stocks. This coincided with the pause in interest rates and expectations of the seasonal year-end rally. 
Via Talk Markets

Performance

YTD
-2.71%
-2.71%
1 Month
+19.12%
+19.12%
3 Month
+0.62%
+0.62%
6 Month
-11.07%
-11.07%
1 Year
-0.26%
-0.26%

More News

Read More
Fed Rate Cut Speculations Rattle Stocks, Commodities Slide, Bitcoin Shines: What's Driving Markets Monday?
Via Benzinga
Topics Economy
Exposures Interest Rates
Stocks, Gold, Bonds Rally Further, Dollars Tumbles As Traders Anticipate Fed Cuts: What's Driving Markets Friday?
Via Benzinga
Topics Economy
Exposures Interest Rates
S&P 500, Nasdaq Slip As Tech Underperforms, Oil Reacts to OPEC+: What's Driving Markets Thursday?
Via Benzinga
Topics Stocks
Exposures US Equities
Stocks Drift Higher On Stronger GDP Data, Oil Rebounds As OPEC+ Mulls Cuts: What's Driving Markets Wednesday?
Via Benzinga
US Stocks Rebound As Treasury Yields, Dollar Fall On Dovish Fed Remarks, Gold Hits $2,040: What's Driving Markets Tuesday?
Via Benzinga
Topics Economy
Exposures Interest Rates
Biotech And Healthcare Portfolio Playbook For December 2023/24
Via Talk Markets
Are You A Trader Or Investor: Biotech Momentum Is Picking Up
Via Talk Markets
Topics ETFs
3 Biotech Stocks That Could Boom or Bust by 2025
Via InvestorPlace
Healthcare Playbook: Hardly Defensive With A Covid Hangover In Biotech
Via Talk Markets
Exposures COVID-19
This Week’s Data Dump May Lead To More Stock Market Pain
Via Talk Markets
It's Hard to Be a Biotech Bull in This Market, but This Stock Is a Buy
Via The Motley Fool
Pivotal Week Coming Up: Big Tech Earnings, Geopolitics, Technicals, Treasury Yield...
Via Talk Markets
Topics Economy
Exposures Economy
Thoughts For Thursday: War Worries Rattle The Market
Via Talk Markets
Too Much To Handle For Stocks As Rates Continue To Rise
Via Talk Markets
Topics Economy Stocks
Exposures Interest Rates US Equities
Stocks and Bonds Go Their Separate Ways
Via Talk Markets
Topics Stocks
Exposures US Equities
Large Cap Biopharmaceuticals-Core Holdings For Your Healthcare Portfolio Until M&A Action Picks Up
Via Talk Markets
Stocks Rally And Rates Drop But Trends Remain In Place
Via Talk Markets
Don’t Miss the Boom: 3 ETFs Set to Explode Higher
Via InvestorPlace
Topics ETFs
Healthcare Playbook Revisited - Growth Plus Value
Via Talk Markets
Buy List Alert: 3 Pharma Stocks with Positive Trial Updates
Via InvestorPlace
EXCLUSIVE: Kidney Care Revolution? How Swedish Biopharma Calliditas Aims To Tackle A Rare Disease With 'Unique, But Pretty Simple' Drug
Via Benzinga
Healthcare Portfolio: A Mixed Market Looking for Value
Via Talk Markets
Life Science Mutual Funds Compared To ETFs And What Is In Your Portfolio?
Via Talk Markets
Topics ETFs
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.